A Non-Face-to-Face Physical Activity Promotion Program for University Students

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Physical Activity Interventions: Behavioral: Non-Face-to-Face Leisure-Time Physical Activity Promotion Program Sponsors: Seoul National University Completed Conditions: Physical Activity Interventions: Behavioral: Non-Face-to-Face Leisure-Time Physical...

Impact of Therapeutic Storytelling on Fear, Screen Time, and Parental Stress Among Hospitalized Children

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Hospitalized Children; Parent Stress Interventions: Behavioral: Therapeutic Story Telling; Other: routine care Sponsors: Karabuk University Completed Conditions: Hospitalized Children; Parent Stress Interventions: Behavioral: Therapeutic Story Telling;...

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Healthy Participants; Pharmacokinetics Interventions: Drug: Evolocumab Drug Substance A; Drug: Evolocumab Drug Substance B Sponsors: Amgen Recruiting Conditions: Healthy Participants; Pharmacokinetics Interventions: Drug: Evolocumab Drug Substance A;...

A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Glioblastoma Interventions: Biological: B-cell vaccination Sponsors: Catalina Lee Chang Not yet recruiting Conditions: Glioblastoma Interventions: Biological: B-cell vaccination Sponsors: Catalina Lee Chang Not yet...

Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Depression – Major Depressive Disorder; Depression Disorder; Depression Chronic; Treatment-Resistant Major Depressive Disorder Interventions: Behavioral: Virtual-Reality-based mindfulness intervention; Drug: Esketamine Treatment as Usual (ESK)...